{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:43:15Z","timestamp":1786120995167,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04663-3","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T01:59:27Z","timestamp":1786067967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The histopathological differential diagnosis of BPDCN and other plasmacytoid dendritic cell proliferations"],"prefix":"10.1007","author":[{"given":"Gabriele","family":"Giudice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3258-0727","authenticated-orcid":false,"given":"Arturo","family":"Bonometti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"8","key":"4663_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/leu.2014.64","volume":"28","author":"MR Sapienza","year":"2014","unstructured":"Sapienza MR, Fuligni F, Agostinelli C et al (2014) Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. Leukemia 28(8):1606\u20131616. https:\/\/doi.org\/10.1038\/leu.2014.64","journal-title":"Leukemia"},{"issue":"5","key":"4663_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/bloodadvances.2020003359","volume":"5","author":"F Renosi","year":"2021","unstructured":"Renosi F, Roggy A, Giguelay A et al (2021) Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis. Blood Adv 5(5):1540\u20131551. https:\/\/doi.org\/10.1182\/bloodadvances.2020003359","journal-title":"Blood Adv"},{"issue":"1","key":"4663_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-immunol-090122-041105","volume":"42","author":"NM Adams","year":"2024","unstructured":"Adams NM, Das A, Yun TJ, Reizis B (2024) Ontogeny and Function of Plasmacytoid Dendritic Cells. Annu Rev Immunol 42(1):347\u2013373. https:\/\/doi.org\/10.1146\/annurev-immunol-090122-041105","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"4663_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nri3712","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams M, Ginhoux F, Jakubzick C et al (2014) Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 14(8):571\u2013578. https:\/\/doi.org\/10.1038\/nri3712","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4663_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000205666","volume":"21","author":"K Lennert","year":"1959","unstructured":"Lennert K, Remmele W (1959) Karyometrische Untersuchungen an Lymphknotenzellen des Menschen III. Mitteilung: Basophile Stainmzellen, Plasmazellen und Gewebsmastzellen. Acta Haematol 21(3):139\u2013155. https:\/\/doi.org\/10.1159\/000205666","journal-title":"Acta Haematol"},{"issue":"6","key":"4663_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11899-018-0489-z","volume":"13","author":"JD Khoury","year":"2018","unstructured":"Khoury JD (2018) Blastic Plasmacytoid Dendritic Cell Neoplasm. Curr Hematol Malig Rep 13(6):477\u2013483. https:\/\/doi.org\/10.1007\/s11899-018-0489-z","journal-title":"Curr Hematol Malig Rep"},{"issue":"11","key":"4663_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP et al (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"4663_CR8","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC."},{"issue":"1","key":"4663_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.24069","volume":"65","author":"K Sakamoto","year":"2025","unstructured":"Sakamoto K, Takeuchi K (2025) Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding. J Clin Exp Hematop 65(1):1\u201316. https:\/\/doi.org\/10.3960\/jslrt.24069","journal-title":"J Clin Exp Hematop"},{"issue":"2","key":"4663_CR10","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1111\/ajd.13491","volume":"62","author":"A Bonometti","year":"2021","unstructured":"Bonometti A, Gliozzo J, Moltrasio C, Bagnoli F, Berti E (2021) Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases. Australas J Dermatol 62(2):e162\u2013e169. https:\/\/doi.org\/10.1111\/ajd.13491","journal-title":"Australas J Dermatol"},{"issue":"1","key":"4663_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/cjp2.177","volume":"7","author":"PG Kemps","year":"2021","unstructured":"Kemps PG, Hebeda KM, Pals ST et al (2021) Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation. J Pathol Clin Res 7(1):10\u201326. https:\/\/doi.org\/10.1002\/cjp2.177","journal-title":"J Pathol Clin Res"},{"issue":"9","key":"4663_CR12","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/PAS.0b013e31825dd4de","volume":"36","author":"F Vitte","year":"2012","unstructured":"Vitte F, Fabiani B, B\u00e9net C et al (2012) Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Am J Surg Pathol 36(9):1302\u20131316. https:\/\/doi.org\/10.1097\/PAS.0b013e31825dd4de","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"4663_CR13","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/cncr.10489","volume":"94","author":"JD Khoury","year":"2002","unstructured":"Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D (2002) CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 94(9):2401\u20132408. https:\/\/doi.org\/10.1002\/cncr.10489","journal-title":"Cancer"},{"issue":"12","key":"4663_CR14","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/ajh.23567","volume":"88","author":"K Alayed","year":"2013","unstructured":"Alayed K, Patel KP, Konoplev S et al (2013) TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow. Am J Hematol 88(12):1055\u20131061. https:\/\/doi.org\/10.1002\/ajh.23567","journal-title":"Am J Hematol"},{"issue":"5","key":"4663_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bjh.18632","volume":"200","author":"S El Hussein","year":"2023","unstructured":"El Hussein S, Wang W (2023) Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations. Br J Haematol 200(5):545\u2013555. https:\/\/doi.org\/10.1111\/bjh.18632","journal-title":"Br J Haematol"},{"issue":"3","key":"4663_CR16","doi-asserted-by":"publisher","first-page":"e841","DOI":"10.1097\/hs9.0000000000000841","volume":"7","author":"L Pagano","year":"2023","unstructured":"Pagano L, Zinzani PL, Pileri S et al (2023) Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel. HemaSphere 7(3):e841. https:\/\/doi.org\/10.1097\/hs9.0000000000000841","journal-title":"HemaSphere"},{"key":"4663_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.leukres.2018.08.014","volume":"73","author":"GS Guru Murthy","year":"2018","unstructured":"Guru Murthy GS, Pemmaraju N, Atallah E (2018) Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm. Leuk Res 73:21\u201323. https:\/\/doi.org\/10.1016\/j.leukres.2018.08.014","journal-title":"Leuk Res"},{"issue":"13","key":"4663_CR18","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.3390\/ijms25137099","volume":"25","author":"C Di Raimondo","year":"2024","unstructured":"Di Raimondo C, Lozzi F, Di Domenico PP et al (2024) Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View. Int J Mol Sci 25(13):7099. https:\/\/doi.org\/10.3390\/ijms25137099","journal-title":"Int J Mol Sci"},{"issue":"7966","key":"4663_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41586-023-06156-8","volume":"618","author":"GK Griffin","year":"2023","unstructured":"Griffin GK, Booth CAG, Togami K et al (2023) Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin. Nature 618(7966):834\u2013841. https:\/\/doi.org\/10.1038\/s41586-023-06156-8","journal-title":"Nature"},{"issue":"5","key":"4663_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.6004\/jnccn.2023.7026","volume":"21","author":"A Jain","year":"2023","unstructured":"Jain A, Sweet K (2023) Blastic Plasmacytoid Dendritic Cell Neoplasm. J Natl Compr Canc Netw 21(5):515\u2013521. https:\/\/doi.org\/10.6004\/jnccn.2023.7026","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"4663_CR21","doi-asserted-by":"publisher","first-page":"10174","DOI":"10.18632\/oncotarget.7101","volume":"7","author":"L Mart\u00edn-Mart\u00edn","year":"2016","unstructured":"Mart\u00edn-Mart\u00edn L, Almeida J, Pomares H et al (2016) Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy. Oncotarget 7(9):10174\u201310181. https:\/\/doi.org\/10.18632\/oncotarget.7101","journal-title":"Oncotarget"},{"issue":"1","key":"4663_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","volume":"34","author":"C Cota","year":"2010","unstructured":"Cota C, Vale E, Viana I et al (2010) Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm\u2014Morphologic and Phenotypic Variability in a Series of 33 Patients. Am J Surg Pathol 34(1):75\u201387. https:\/\/doi.org\/10.1097\/PAS.0b013e3181c5e26b","journal-title":"Am J Surg Pathol"},{"key":"4663_CR23","unstructured":"WHO Classification of Tumours Editorial Board (2024) Haematolymphoid Tumours. WHO classification of tumours series, 5th ed.; vol. 11. Lyon (France): International Agency for Research on Cancer"},{"issue":"2","key":"4663_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/bjh.14146","volume":"174","author":"L Pagano","year":"2016","unstructured":"Pagano L, Valentini CG, Grammatico S, Pulsoni A (2016) Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol 174(2):188\u2013202. https:\/\/doi.org\/10.1111\/bjh.14146","journal-title":"Br J Haematol"},{"issue":"3","key":"4663_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/cells13030243","volume":"13","author":"S Mehra","year":"2024","unstructured":"Mehra S, Taylor J (2024) Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies. Cells 13(3):243. https:\/\/doi.org\/10.3390\/cells13030243","journal-title":"Cells"},{"issue":"18","key":"4663_CR26","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.3390\/cancers13184680","volume":"13","author":"MR Sapienza","year":"2021","unstructured":"Sapienza MR, Benvenuto G, Ferracin M et al (2021) Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers 13(18):4680. https:\/\/doi.org\/10.3390\/cancers13184680","journal-title":"Cancers"},{"issue":"2","key":"4663_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.2012.072645","volume":"98","author":"L Pagano","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A et al (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98(2):239\u2013246. https:\/\/doi.org\/10.3324\/haematol.2012.072645","journal-title":"Haematologica"},{"issue":"11","key":"4663_CR28","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3390\/cancers16112118","volume":"16","author":"S El Hussein","year":"2024","unstructured":"El Hussein S, Wang W (2024) Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms. Cancers 16(11):2118. https:\/\/doi.org\/10.3390\/cancers16112118","journal-title":"Cancers"},{"issue":"12","key":"4663_CR29","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/s41375-018-0154-5","volume":"32","author":"K Sakamoto","year":"2018","unstructured":"Sakamoto K, Katayama R, Asaka R et al (2018) Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response. Leukemia 32(12):2590\u20132603. https:\/\/doi.org\/10.1038\/s41375-018-0154-5","journal-title":"Leukemia"},{"issue":"5","key":"4663_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/cancers11050595","volume":"11","author":"MR Sapienza","year":"2019","unstructured":"Sapienza MR, Pileri A, Derenzini E et al (2019) Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects. Cancers 11(5):595. https:\/\/doi.org\/10.3390\/cancers11050595","journal-title":"Cancers"},{"key":"4663_CR31","doi-asserted-by":"publisher","unstructured":"Egan C, Song S, Liu W, ping et al (2025) Plasmacytoid dendritic cell proliferations, malignant histiocytic (macrophage\/dendritic cell) neoplasms and follicular dendritic cell neoplasms: report from the 2024 Joint CSHP\/EA4HP\/SH workshop. Virchows Arch. Published online June 24. https:\/\/doi.org\/10.1007\/s00428-025-04114-5","DOI":"10.1007\/s00428-025-04114-5"},{"issue":"24","key":"4663_CR32","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","volume":"3","author":"F Garnache-Ottou","year":"2019","unstructured":"Garnache-Ottou F, Vidal C, Biichl\u00e9 S et al (2019) How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Adv 3(24):4238\u20134251. https:\/\/doi.org\/10.1182\/bloodadvances.2019000647","journal-title":"Blood Adv"},{"issue":"7","key":"4663_CR33","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"issue":"12","key":"4663_CR34","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1182\/blood-2002-10-3297","volume":"101","author":"M Herling","year":"2003","unstructured":"Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D (2003) TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4\u2009+\u2009CD56+ blastic tumors of skin. Blood 101(12):5007\u20135009. https:\/\/doi.org\/10.1182\/blood-2002-10-3297","journal-title":"Blood"},{"issue":"4","key":"4663_CR35","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3324\/haematol.2020.247569","volume":"106","author":"W Wang","year":"2021","unstructured":"Wang W, Khoury JD, Miranda RN et al (2021) Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm. Haematologica 106(4):1047\u20131055. https:\/\/doi.org\/10.3324\/haematol.2020.247569","journal-title":"Haematologica"},{"issue":"4","key":"4663_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00277-026-06829-0","volume":"105","author":"F Renosi","year":"2026","unstructured":"Renosi F, Biichl\u00e9 S, Roussel X et al (2026) Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms. Ann Hematol 105(4):122. https:\/\/doi.org\/10.1007\/s00277-026-06829-0","journal-title":"Ann Hematol"},{"issue":"17","key":"4663_CR37","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.3390\/cancers14174132","volume":"14","author":"F Renosi","year":"2022","unstructured":"Renosi F, Callanan M, Lefebvre C (2022) Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells. Cancers 14(17):4132. https:\/\/doi.org\/10.3390\/cancers14174132","journal-title":"Cancers"},{"issue":"2","key":"4663_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.path.2026.01.012","volume":"19","author":"H Goulart","year":"2026","unstructured":"Goulart H, Loghavi S (2026) Molecular Pathology of Myeloid Neoplasms. Surg Pathol Clin 19(2):213\u2013225. https:\/\/doi.org\/10.1016\/j.path.2026.01.012","journal-title":"Surg Pathol Clin"},{"key":"4663_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1471-2407-12-304","volume":"12","author":"A Murati","year":"2012","unstructured":"Murati A, Brecqueville M, Devillier R, Mozziconacci MJ, Gelsi-Boyer V, Birnbaum D (2012) Myeloid malignancies: mutations, models and management. BMC Cancer 12:304. https:\/\/doi.org\/10.1186\/1471-2407-12-304","journal-title":"BMC Cancer"},{"issue":"24","key":"4663_CR40","doi-asserted-by":"publisher","first-page":"e183889","DOI":"10.1172\/jci.insight.183889","volume":"9","author":"CAG Booth","year":"2024","unstructured":"Booth CAG, Bouyssou JM, Togami K et al (2024) BPDCN MYB fusions regulate cell cycle genes, impair differentiation, and induce myeloid\u2013dendritic cell leukemia. JCI Insight 9(24):e183889. https:\/\/doi.org\/10.1172\/jci.insight.183889","journal-title":"JCI Insight"},{"key":"4663_CR41","doi-asserted-by":"publisher","unstructured":"Khanlari M, Nunez MT, Maciaszek JL et al (2026) Pediatric blastic plasmacytoid dendritic cell neoplasms are molecularly defined by recurrent MYB rearrangements: clinical and molecular insights. Haematologica Published online May 7. https:\/\/doi.org\/10.3324\/haematol.2026.300903","DOI":"10.3324\/haematol.2026.300903"},{"issue":"7","key":"4663_CR42","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/leu.2017.101","volume":"31","author":"K Suzuki","year":"2017","unstructured":"Suzuki K, Suzuki Y, Hama A et al (2017) Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm. Leukemia 31(7):1629\u20131633. https:\/\/doi.org\/10.1038\/leu.2017.101","journal-title":"Leukemia"},{"issue":"5","key":"4663_CR43","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","volume":"99","author":"J Feuillard","year":"2002","unstructured":"Feuillard J (2002) Clinical and biologic features of CD4\u2009+\u2009CD56+ malignancies. Blood 99(5):1556\u20131563. https:\/\/doi.org\/10.1182\/blood.V99.5.1556","journal-title":"Blood"},{"issue":"1","key":"4663_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2133.2009.09373.x","volume":"162","author":"S Dalle","year":"2010","unstructured":"Dalle S, Beylot-Barry M, Bagot M et al (2010) Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? BPDCN: is transplantation the treatment of choice? Br J Dermatol 162(1):74\u201379. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09373.x","journal-title":"Br J Dermatol"},{"issue":"8","key":"4663_CR45","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.bbmt.2010.12.706","volume":"17","author":"S Dietrich","year":"2011","unstructured":"Dietrich S, Andrulis M, Hegenbart U et al (2011) Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity. Biol Blood Marrow Transpl 17(8):1250\u20131254. https:\/\/doi.org\/10.1016\/j.bbmt.2010.12.706","journal-title":"Biol Blood Marrow Transpl"},{"issue":"19","key":"4663_CR46","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1182\/bloodadvances.2020002474","volume":"4","author":"K Laribi","year":"2020","unstructured":"Laribi K, De Baugier A, Sobh M et al (2020) Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients. Blood Adv 4(19):4838\u20134848. https:\/\/doi.org\/10.1182\/bloodadvances.2020002474","journal-title":"Blood Adv"},{"issue":"26","key":"4663_CR47","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1200\/JCO.22.00034","volume":"40","author":"N Pemmaraju","year":"2022","unstructured":"Pemmaraju N, Sweet KL, Stein AS et al (2022) Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. J Clin Oncol 40(26):3032\u20133036. https:\/\/doi.org\/10.1200\/JCO.22.00034","journal-title":"J Clin Oncol"},{"issue":"17","key":"4663_CR48","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","volume":"380","author":"N Pemmaraju","year":"2019","unstructured":"Pemmaraju N, Lane AA, Sweet KL et al (2019) Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med 380(17):1628\u20131637. https:\/\/doi.org\/10.1056\/NEJMoa1815105","journal-title":"N Engl J Med"},{"issue":"Supplement 1","key":"4663_CR49","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1182\/blood-2023-172953","volume":"142","author":"M Sandhu","year":"2023","unstructured":"Sandhu M, Ashok Kumar P, Kumar VS, Batayneh O, Metpalli SV, Gentile T (2023) Evaluation of Treatment Outcomes in Adults with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Review and Meta-Analysis. Blood 142(Supplement 1):4210\u20134210. https:\/\/doi.org\/10.1182\/blood-2023-172953","journal-title":"Blood"},{"issue":"8","key":"4663_CR50","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood.2019001144","volume":"134","author":"J Taylor","year":"2019","unstructured":"Taylor J, Haddadin M, Upadhyay VA et al (2019) Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark. Blood 134(8):678\u2013687. https:\/\/doi.org\/10.1182\/blood.2019001144","journal-title":"Blood"},{"issue":"3","key":"4663_CR51","first-page":"213","volume":"13","author":"JM Meis-Kindblom","year":"1996","unstructured":"Meis-Kindblom JM, Stenman G, Kindblom LG (1996) Differential diagnosis of small round cell tumors. Semin Diagn Pathol 13(3):213\u2013241","journal-title":"Semin Diagn Pathol"},{"key":"4663_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.humpath.2024.01.007","volume":"147","author":"CA Dehner","year":"2024","unstructured":"Dehner CA, Lazar AJ, Chrisinger JSA (2024) Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else. Hum Pathol 147:101\u2013113. https:\/\/doi.org\/10.1016\/j.humpath.2024.01.007","journal-title":"Hum Pathol"},{"issue":"3","key":"4663_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/cup.13910","volume":"48","author":"NM Walsh","year":"2021","unstructured":"Walsh NM, Cerroni L (2021) Merkel cell carcinoma: A review. J Cutan Pathol 48(3):411\u2013421. https:\/\/doi.org\/10.1111\/cup.13910","journal-title":"J Cutan Pathol"},{"key":"4663_CR54","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000503703","volume":"27","author":"S Ronen","year":"2019","unstructured":"Ronen S, Czaja RC, Ronen N, Pantazis CG, Iczkowski KA (2019) Small Cell Variant of Metastatic Melanoma: A Mimicker of Lymphoblastic Leukemia\/Lymphoma. Dermatopathology Published online November 27:231\u2013236. https:\/\/doi.org\/10.1159\/000503703","journal-title":"Dermatopathology Published online November"},{"issue":"15","key":"4663_CR55","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.3390\/cancers15153928","volume":"15","author":"M Zanelli","year":"2023","unstructured":"Zanelli M, Sanguedolce F, Zizzo M et al (2023) Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential Diagnoses. Cancers 15(15):3928. https:\/\/doi.org\/10.3390\/cancers15153928","journal-title":"Cancers"},{"issue":"6","key":"4663_CR56","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/ajh.27271","volume":"99","author":"MM Patnaik","year":"2024","unstructured":"Patnaik MM, Tefferi A (2024) Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. Am J Hematol 99(6):1142\u20131165. https:\/\/doi.org\/10.1002\/ajh.27271","journal-title":"Am J Hematol"},{"key":"4663_CR57","doi-asserted-by":"publisher","unstructured":"Yousuf M, Faldu P, Abdelmagid M et al (2025) A retrospective analysis of upfront treatment strategies in chronic myelomonocytic leukemia: impact on survival and response patterns. Haematologica Published online Oct 16. https:\/\/doi.org\/10.3324\/haematol.2025.288006","DOI":"10.3324\/haematol.2025.288006"},{"issue":"12","key":"4663_CR58","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1080\/10428194.2018.1452212","volume":"59","author":"K Hoversten","year":"2018","unstructured":"Hoversten K, Vallapureddy R, Lasho T et al (2018) Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates. Leuk Lymphoma 59(12):2998\u20133001. https:\/\/doi.org\/10.1080\/10428194.2018.1452212","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"4663_CR59","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","volume":"33","author":"N Lucas","year":"2019","unstructured":"Lucas N, Duchmann M, Rameau P et al (2019) Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia. Leukemia 33(10):2466\u20132480. https:\/\/doi.org\/10.1038\/s41375-019-0447-3","journal-title":"Leukemia"},{"key":"4663_CR60","doi-asserted-by":"publisher","unstructured":"Zanella S, Berti E, Bonometti A, for Associazione Italiana Ricerca Istiocitosi ONLUS (2023) Indeterminate cell histiocytosis: A systematic review of the literature with a comprehensive revision of clinical, histopathological, and molecular features. J Eur Acad Dermatol Venereol JEADV Published online April 5. https:\/\/doi.org\/10.1111\/jdv.19095","DOI":"10.1111\/jdv.19095"},{"issue":"2","key":"4663_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1309\/AJCPFMNYCVPDEND0","volume":"135","author":"C B\u00e9net","year":"2011","unstructured":"B\u00e9net C, Gomez A, Aguilar C et al (2011) Histologic and Immunohistologic Characterization of Skin Localization of Myeloid Disorders. Am J Clin Pathol 135(2):278\u2013290. https:\/\/doi.org\/10.1309\/AJCPFMNYCVPDEND0","journal-title":"Am J Clin Pathol"},{"key":"4663_CR62","doi-asserted-by":"publisher","first-page":"154548","DOI":"10.1016\/j.prp.2023.154548","volume":"247","author":"A Fiegl","year":"2023","unstructured":"Fiegl A, Dirnhofer S, Juskevicius D et al (2023) Testicular Rosai-Dorfman disease clonally related to CMML - Case report and literature review. Pathol Res Pract 247:154548. https:\/\/doi.org\/10.1016\/j.prp.2023.154548","journal-title":"Pathol Res Pract"},{"issue":"2","key":"4663_CR63","doi-asserted-by":"publisher","first-page":"e70079","DOI":"10.1002\/2056-4538.70079","volume":"12","author":"A Jenei","year":"2026","unstructured":"Jenei A, Kajt\u00e1r B, L\u00e1szl\u00f3 T et al (2026) Frequent NPM1 mutation, monoblastic\/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study. J Pathol Clin Res 12(2):e70079. https:\/\/doi.org\/10.1002\/2056-4538.70079","journal-title":"J Pathol Clin Res"},{"issue":"3","key":"4663_CR64","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/ajcp\/aqae133","volume":"163","author":"A Jenei","year":"2025","unstructured":"Jenei A, Tzankov A (2025) Diagnostic approach to leukemia cutis: A differential diagnostic step-by-step algorithm. Am J Clin Pathol 163(3):395\u2013405. https:\/\/doi.org\/10.1093\/ajcp\/aqae133","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"4663_CR65","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/cancers15051443","volume":"15","author":"KE Zorn","year":"2023","unstructured":"Zorn KE, Cunningham AM, Meyer AE, Carlson KS, Rao S (2023) Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology. Cancers 15(5):1443. https:\/\/doi.org\/10.3390\/cancers15051443","journal-title":"Cancers"},{"issue":"3","key":"4663_CR66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1053\/j.semdp.2023.04.009","volume":"40","author":"M Ramia De Cap","year":"2023","unstructured":"Ramia De Cap M, Chen W (2023) Myeloid sarcoma: An overview. Semin Diagn Pathol 40(3):129\u2013139. https:\/\/doi.org\/10.1053\/j.semdp.2023.04.009","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"4663_CR67","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1002\/2056-4538.70044","volume":"11","author":"D Nann","year":"2025","unstructured":"Nann D, Schade T, Overkamp M et al (2025) Myeloid sarcoma shows a high frequency of mutations activating the MAPK\/ERK pathway and association with clonal hematopoiesis. J Pathol Clin Res 11(5):e70044. https:\/\/doi.org\/10.1002\/2056-4538.70044","journal-title":"J Pathol Clin Res"},{"issue":"2","key":"4663_CR68","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.leu.2404491","volume":"21","author":"SA Pileri","year":"2007","unstructured":"Pileri SA, Ascani S, Cox MC et al (2007) Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21(2):340\u2013350. https:\/\/doi.org\/10.1038\/sj.leu.2404491","journal-title":"Leukemia"},{"issue":"2","key":"4663_CR69","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1590\/abd1806-4841.20186327","volume":"93","author":"L Li","year":"2018","unstructured":"Li L, Wang Y, Lian CG, Hu N, Jin H, Liu Y (2018) Clinical and pathological features of myeloid leukemia cutis. Bras Dermatol 93(2):216\u2013221. https:\/\/doi.org\/10.1590\/abd1806-4841.20186327","journal-title":"Bras Dermatol"},{"issue":"1","key":"4663_CR70","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10428194.2024.2404247","volume":"66","author":"A Bonometti","year":"2025","unstructured":"Bonometti A, Tzankov A, Alborelli I, Went P, Dirnhofer S (2025) CD1a\u2009+\u2009histiocytoses in primary myelofibrosis patients: just a casual association? A case report and systematic review of the literature. Leuk Lymphoma 66(1):139\u2013146. https:\/\/doi.org\/10.1080\/10428194.2024.2404247","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"4663_CR71","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.1182\/bloodadvances.2024013545","volume":"8","author":"N Ozkaya","year":"2024","unstructured":"Ozkaya N, Melloul Benizri S, Venkataraman G et al (2024) Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms. Blood Adv 8(22):5796\u20135805. https:\/\/doi.org\/10.1182\/bloodadvances.2024013545","journal-title":"Blood Adv"},{"issue":"12","key":"4663_CR72","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3324\/haematol.2020.253740","volume":"106","author":"L Zalma\u00ef","year":"2020","unstructured":"Zalma\u00ef L, Viailly PJ, Biichle S et al (2020) Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape. Haematologica 106(12):3056\u20133066. https:\/\/doi.org\/10.3324\/haematol.2020.253740","journal-title":"Haematologica"},{"key":"4663_CR73","doi-asserted-by":"publisher","unstructured":"Minetto P, Guolo F, Clavio M et al (2018) A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1\u2010mutated acute myeloid leukemia patients with worse prognosis. Am J Hematol 93(2). https:\/\/doi.org\/10.1002\/ajh.24956","DOI":"10.1002\/ajh.24956"},{"issue":"2","key":"4663_CR74","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00277-023-05594-8","volume":"103","author":"J Song","year":"2024","unstructured":"Song J, Li W, Bai Y et al (2024) A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Ann Hematol 103(2):463\u2013473. https:\/\/doi.org\/10.1007\/s00277-023-05594-8","journal-title":"Ann Hematol"},{"key":"4663_CR75","doi-asserted-by":"publisher","first-page":"105766","DOI":"10.1016\/j.humpath.2025.105766","volume":"158","author":"H Hamdan","year":"2025","unstructured":"Hamdan H, Siddon A, Ramia De Cap M et al (2025) Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasms. Hum Pathol 158:105766. https:\/\/doi.org\/10.1016\/j.humpath.2025.105766","journal-title":"Hum Pathol"},{"issue":"8","key":"4663_CR76","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/sj.leu.2402174","volume":"15","author":"D Raspadori","year":"2001","unstructured":"Raspadori D, Damiani D, Lenoci M et al (2001) CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis. Leukemia 15(8):1161\u20131164. https:\/\/doi.org\/10.1038\/sj.leu.2402174","journal-title":"Leukemia"},{"issue":"S1","key":"4663_CR77","first-page":"116","volume":"9","author":"I Navarro-Vicente","year":"2025","unstructured":"Navarro-Vicente I, Rodr\u00edguez-Veiga R, Boluda B (2025) Real-World Outcomes in a Series of 417 Adult Patients with KMT2A (MLL) Gene-Rearranged Acute Myeloid Leukemia. HemaSphere 9(S1):116\u2013118","journal-title":"HemaSphere"},{"issue":"10","key":"4663_CR78","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood.2020007897","volume":"137","author":"W Xiao","year":"2021","unstructured":"Xiao W, Chan A, Waarts MR et al (2021) Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia. Blood 137(10):1377\u20131391. https:\/\/doi.org\/10.1182\/blood.2020007897","journal-title":"Blood"},{"issue":"Supplement 1","key":"4663_CR79","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1182\/blood-2018-99-119081","volume":"132","author":"W Xiao","year":"2018","unstructured":"Xiao W, Goldberg AD, Famulare C et al (2018) Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation: Predominantly Secondary AML, Enriched for RUNX1 Mutations, Frequent Cross-Lineage Antigen Expression and Poor Prognosis. Blood 132(Supplement 1):2789\u20132789. https:\/\/doi.org\/10.1182\/blood-2018-99-119081","journal-title":"Blood"},{"key":"4663_CR80","doi-asserted-by":"publisher","first-page":"232470962513447","DOI":"10.1177\/23247096251344723","volume":"13","author":"J Al-Nusair","year":"2025","unstructured":"Al-Nusair J, Porter N, Alagha Z, Graffeo V, Mahmud W, Alshal M (2025) Nodal Mature Plasmacytoid Dendritic Cell Proliferation in a Patient With Chronic Myelomonocytic Leukemia: A Diagnostic Mimic of Blastic Plasmacytoid Dendritic Cell Neoplasm. J Investig Med High Impact Case Rep 13:23247096251344723. https:\/\/doi.org\/10.1177\/23247096251344723","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"5","key":"4663_CR81","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00277-017-2947-4","volume":"96","author":"A Tzankov","year":"2017","unstructured":"Tzankov A, Hebeda K, Kremer M et al (2017) Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow: Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016. Ann Hematol 96(5):765\u2013777. https:\/\/doi.org\/10.1007\/s00277-017-2947-4","journal-title":"Ann Hematol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04663-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04663-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04663-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T01:59:29Z","timestamp":1786067969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04663-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":81,"alternative-id":["4663"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04663-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No Human Participants and\/or Animals have been involved in this study.","order":3,"name":"Ethics","label":"Research involving human participants and\/or animals","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing financial interests.","order":4,"name":"Ethics","label":"Conflict of interest disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}]}}